| Recruiting | A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants Retinitis Pigmentosa | Phase 1 / Phase 2 | 2026-04-16 |
| Recruiting | How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients Wi Advanced Hematologic Malignancies | Phase 1 | 2026-03-26 |
| Recruiting | A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Pa Parkinson's Disease | Phase 1 / Phase 2 | 2024-12-18 |
| Active Not Recruiting | A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP) Retinitis Pigmentosa | — | 2024-10-03 |
| Recruiting | SMP-3124LP in Adults With Advanced Solid Tumors Solid Tumor | Phase 1 / Phase 2 | 2024-08-14 |
| Completed | TP-3654 Food Effect Study Myelofibroses | Phase 1 | 2024-03-04 |
| Completed | A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Social Anxiety Disorder (SAD) | N/A | 2023-09-08 |
| Completed | Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654 Healthy | Phase 1 | 2023-05-22 |
| Completed | Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetat Prostate Cancer | Phase 3 | 2023-01-25 |
| Active Not Recruiting | A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX Prostate Cancer | — | 2022-10-04 |
| Terminated | A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Depressive Episodes, Bipolar I Depression | Phase 3 | 2022-03-17 |
| Recruiting | A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma | Phase 1 / Phase 2 | 2022-02-28 |
| Terminated | A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipo Depressive Episodes, Bipolar I Depression | Phase 3 | 2021-12-21 |
| Active Not Recruiting | Study of DSP-0390 in Patients With Recurrent High-Grade Glioma High Grade Glioma, Glioblastoma Multiforme | EARLY_Phase 1 | 2021-09-08 |
| Completed | Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer | Phase 1 | 2021-02-18 |
| Terminated | A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS Anemia in Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2020-12-28 |
| Completed | Phase 1 Study of Oral TP-1454 Advanced Solid Tumor, Anal Cancer | Phase 1 | 2020-07-08 |
| Completed | Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Oncology | Phase 1 | 2020-02-24 |
| Terminated | Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Th Acute Myeloid Leukemia (AML) | Phase 2 | 2020-01-15 |
| Recruiting | A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis Myelofibrosis | Phase 1 / Phase 2 | 2019-12-16 |
| Terminated | Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL Chronic Lymphocytic Leukemia, CLL, SLL | Phase 1 / Phase 2 | 2019-06-10 |
| Completed | Study of TP-3654 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2019-04-16 |
| Terminated | Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors Advanced Solid Tumors, Sarcoma, Ewing Sarcoma | Phase 1 | 2018-12-26 |
| Completed | A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Mo Motor OFF Episodes Associated With Parkinson's Disease | Phase 3 | 2018-12-19 |
| Terminated | A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS Myelodysplastic Syndromes (MDS) | Phase 1 / Phase 2 | 2018-08-29 |
| Completed | First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2018-07-10 |
| Completed | A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressi Depressive Episode, Bipolar 1 Depression | Phase 2 | 2018-06-26 |
| Completed | A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia Schizophrenia | Phase 1 | 2018-06-07 |
| Terminated | A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Pro Neoplasms | Phase 1 / Phase 2 | 2018-06-01 |
| Completed | A Study to Evaluate the Mass Balance of 14C-Napabucasin in Healthy Adult Male Subjects ADME, Healthy | Phase 1 | 2018-05-18 |
| Terminated | A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Pro Neoplasms | Phase 1 | 2018-05-15 |
| Terminated | A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Ad Renal Cell Carcinoma (RCC), Urothelial Carcinoma, Primary Peritoneal Cancer | Phase 1 / Phase 2 | 2017-12-14 |
| Completed | A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma | Phase 3 | 2017-12-08 |
| Completed | Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leuke Acute Myeloid Leukemia | Phase 1 | 2017-09-25 |
| Completed | A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Inv Parkinson Disease | Phase 2 | 2017-08-22 |
| Completed | A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's D Parkinson's Disease, Off Episodes of Parkinson Disease | Phase 2 | 2017-08-03 |
| Completed | A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Defici Attention-Deficit Hyperactivity Disorder (ADHD) | Phase 3 | 2017-07-31 |
| Completed | A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Sei Epilepsy With Partial On-set Seizures | Phase 4 | 2017-07-07 |
| Withdrawn | A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Ye Epilepsy | Phase 3 | 2017-07-06 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Drug Interaction Potential of Napabucasin i Drug-drug Interactions | Phase 1 | 2017-06-30 |
| Completed | A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in A Binge Eating Disorder | Phase 3 | 2017-03-31 |
| Terminated | A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors Gastrointestinal Stromal Tumors | Phase 2 | 2017-03-13 |
| Withdrawn | A Study of BBI503 in Adult Patients With Advanced Urologic Malignancies Urologic Malignancies, Renal Cell Carcinoma, Urothelial Carcinoma | Phase 2 | 2017-01-01 |
| Completed | First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors Advanced Solid Tumors, EGFR Positive Non-small Cell Lung Cancer, Colorectal Carcinoma | Phase 1 | 2016-12-14 |
| Completed | A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adeno Carcinoma, Pancreatic Ductal | Phase 3 | 2016-12-01 |
| Terminated | A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanc Carcinoma, Non-Small-Cell Lung | Phase 3 | 2016-11-01 |
| Completed | A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metasta Colorectal Cancer | Phase 3 | 2016-06-01 |
| Completed | Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction Attention Deficit Hyperactivity Disorder (ADHD), Binge-Eating Disorder Disorder | Phase 1 | 2016-05-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Def Attention-Deficit Hyperactivity Disorder (ADHD) | Phase 3 | 2016-04-30 |
| Terminated | Alvocidib Biomarker-driven Phase 2 AML Study Acute Myeloid Leukemia | Phase 2 | 2016-03-14 |
| Completed | Dasotraline Binge Eating Disorder Extension Study Binge Eating Disorder | Phase 3 | 2016-02-29 |
| Terminated | An Exploratory Study of Genetic and Clinical Factors for Serious Skin Reactions Among Users of Eslicarbazepine SCAR | — | 2015-11-30 |
| Completed | A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies Acute Myeloid Leukemia, Myelodysplastic Syndromes, Glioblastoma Multiforme | Phase 1 | 2015-11-01 |
| Completed | Dasotraline Binge Eating Disorder Study Binge Eating Disorder | Phase 2 / Phase 3 | 2015-10-01 |
| Completed | Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated Epilepsy | — | 2015-09-01 |
| Completed | A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer Cancer | Phase 1 | 2015-09-01 |
| Completed | Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acut Parkinson Disease | Phase 3 | 2015-08-31 |
| Completed | A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advance Cancer | Phase 1 | 2015-08-01 |
| Completed | Dasotraline Pediatric Extension Study Attention Deficit Hyperactivity Disorder | Phase 3 | 2015-06-30 |
| Completed | Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson Disease, Off Episodes | Phase 3 | 2015-06-18 |
| Terminated | A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation Cancer, Ovarian Cancer | Phase 2 | 2015-06-01 |
| Completed | A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies Hematologic Malignancy | Phase 1 | 2015-05-01 |
| Completed | A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors Cancer, Advanced Solid Tumors | Phase 1 | 2015-04-01 |
| Completed | Dasotraline Pediatric ADHD Study Attention Deficit Hyperactivity Disorder | Phase 2 / Phase 3 | 2015-04-01 |
| Completed | A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma Glioblastoma | Phase 1 / Phase 2 | 2015-03-01 |
| Completed | A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer Hepatocellular Carcinoma, Cholangiocarcinoma | Phase 2 | 2015-02-01 |
| Completed | Dasotraline Adult ADHD Study Adult Attention Deficit Hyperactivity Disorder | Phase 3 | 2014-12-01 |
| Completed | A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients Wit Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2014-12-01 |
| Terminated | A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic O Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | 2014-11-01 |
| Completed | A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer Gastric Cancer, Gastroesophageal Junction Cancer | Phase 3 | 2014-10-01 |
| Completed | A Study to Examine APL-130277 in Patients With Parkinson's Disease Parkinson's Disease | Phase 2 | 2014-08-31 |
| Completed | A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer Metastatic Pancreatic Adenocarcinoma | Phase 1 | 2014-08-01 |
| Completed | Dasotraline SEP360-105 Pediatric PK/PD Study Pediatric Attention Deficit Hyperactivity Disorder | Phase 1 | 2014-07-01 |
| Terminated | A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Asthma | Phase 3 | 2014-07-01 |
| Completed | Open-label Safety Study in Adults With ADHD Adult Attention Deficit Hyperactivity Disorder | Phase 3 | 2014-06-01 |
| Completed | Lurasidone Pediatric Bipolar Study Bipolar I Depression | Phase 3 | 2014-03-01 |
| Completed | A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Advanced Gastrointestinal Cancer | Phase 1 / Phase 2 | 2014-01-01 |
| Completed | Pediatric Open-Label Extension Study Schizophrenia, Autism, Bipolar Depression | Phase 3 | 2013-09-30 |
| Completed | Pediatric Schizophrenia Efficacy and Safety Study Schizophrenia | Phase 3 | 2013-08-01 |
| Completed | Lurasidone Pediatric Autism Study Autism | Phase 3 | 2013-08-01 |
| Completed | Lurasidone Low-Dose - High-Dose Study Study Schizophrenia | Phase 3 | 2013-05-01 |
| Terminated | A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and It Healthy | Phase 1 | 2012-12-01 |
| Completed | Adult Attention Deficit Hyperactivity Disorder Adult Attention Deficit Hyperactivity Disorder | Phase 2 | 2012-12-01 |
| Completed | A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subje Perennial Allergic Rhinitis | Phase 4 | 2012-09-01 |
| Completed | Clinical Study of WT2725 in Patients With Advanced Malignancies Cancer | Phase 1 | 2012-07-31 |
| Completed | This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability Bipolar I Disorder | Phase 3 | 2012-06-01 |
| Completed | Lurasidone Pediatric Pharmacokinetics Study Schizophrenia, Autism | Phase 1 | 2012-06-01 |
| Completed | A Twelve Week, Open Label Extension Study in Patients With Schizophrenia Schizophrenia | Phase 3 | 2012-04-01 |
| Completed | A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer Colorectal Cancer | Phase 2 | 2012-03-01 |
| Completed | A Phase 1, Open-Label, Single-photon Emission Computed Tomography (SPECT) Study to Evaluate Serotonin and Dopa Healthy | Phase 1 | 2012-02-01 |
| Completed | A Study of BBI503 in Adult Patients With Advanced Solid Tumors Cancer, Advanced Solid Tumors | Phase 1 | 2012-02-01 |
| Withdrawn | Major Depressive Disorder With Mixed Features Major Depressive Disorder | Phase 3 | 2012-01-01 |
| Completed | A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhiniti Seasonal Allergic Rhinitis | Phase 3 | 2011-11-01 |
| Completed | A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinit Perennial Allergic Rhinitis, PAR | Phase 3 | 2011-10-01 |
| Completed | PEARL Schizophrenia Maintenance Schizophrenia | Phase 3 | 2011-09-01 |
| Completed | Major Depressive Disorder With Mixed Features - Extension Major Depressive Disorder | Phase 3 | 2011-09-01 |
| Completed | Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose Major Depressive Disorder With Mixed Features | Phase 3 | 2011-09-01 |
| Completed | Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spr Perennial Allergic Rhinitis | Phase 3 | 2011-07-01 |
| Completed | Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Ad Perennial Allergic Rhinitis, PAR | Phase 3 | 2011-07-01 |
| Completed | Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Bipolar I Disorder | Phase 3 | 2011-06-01 |
| Completed | Lurasidone Extended Use Study Schizophrenia, Bipolar Disorder | Phase 3 | 2011-06-01 |
| Completed | A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhal Allergic Rhinitis (AR) | Phase 1 | 2011-06-01 |
| Completed | A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies Cancer | Phase 1 / Phase 2 | 2011-04-01 |
| Completed | Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticost Perennial Allergic Rhinitis | Phase 3 | 2011-02-01 |
| Completed | Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression Bipolar Depression | Phase 3 | 2010-11-01 |
| Completed | A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder Schizophrenia, Schizoaffective Disorder | Phase 3 | 2010-08-01 |
| Completed | A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switc Schizophrenia, Schizoaffective Disorder | Phase 3 | 2010-06-01 |
| Completed | Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Anti Epilepsy | Phase 3 | 2010-06-01 |
| Completed | A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Perennial Allergic Rhinitis | Phase 3 | 2010-02-01 |
| Completed | Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (H Perennial Allergic Rhinitis | Phase 3 | 2010-01-01 |
| Completed | Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Seasonal Allergic Rhinitis | Phase 3 | 2009-12-01 |
| Completed | Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Health Type 2 Diabetes Mellitus | Phase 1 | 2009-11-01 |
| Completed | A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Pere Allergic Rhinitis, Perennial Allergic Rhinitis | Phase 3 | 2009-08-01 |
| Completed | Eslicarbazepine Acetate Monotherapy Long Term Study Epilepsy | Phase 3 | 2009-08-01 |
| Completed | Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subj Chronic Obstructive Pulmonary Disease | Phase 3 | 2009-06-01 |
| Completed | Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia Insomnia, Attention Deficit Hyperactivity Disorder | Phase 3 | 2009-05-01 |
| Completed | Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder | Phase 1 | 2009-05-01 |
| Completed | Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperac Insomnia, Attention Deficit Hyperactivity Disorder | Phase 3 | 2009-05-01 |
| Completed | Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression Bipolar Depression | Phase 3 | 2009-04-01 |
| Completed | Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) Bipolar Depression | Phase 3 | 2009-04-01 |
| Completed | Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controll Epilepsy With Simple or Complex Partial Onset Seizures | Phase 3 | 2009-04-01 |
| Completed | Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on) Bipolar Depression | Phase 3 | 2009-04-01 |
| Completed | A Study of BBI608 in Adult Patients With Advanced Malignancies Cancer, Advanced Malignancies | Phase 1 | 2009-03-01 |
| Completed | Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia Chronic Schizophrenia | Phase 3 | 2008-12-01 |
| Completed | A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma Asthma | Phase 3 | 2008-12-01 |
| Completed | Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Seasonal Allergic Rhinitis | Phase 3 | 2008-11-01 |
| Completed | Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. Schizophrenia | Phase 3 | 2008-10-01 |
| Completed | Midazolam Drug-Drug Interaction Study With Lurasidone HCl Schizophrenia Patients | Phase 1 | 2008-10-01 |
| Completed | Digoxin Drug-Drug Interaction With Lurasidone HCl Schizophrenia | Phase 1 | 2008-09-01 |
| Completed | RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE Pharmacokinetics, Metabolism | Phase 1 | 2008-08-01 |
| Completed | Rifampin Drug-Drug Interaction Study With Lurasidone HCl Male, Healthy Normal Subjects | Phase 1 | 2008-08-01 |
| Completed | Lithium Drug-Drug Interaction Study With Lurasidone HCl Schizophrenia | Phase 1 | 2008-08-01 |
| Completed | The Bioequivalence Of Two Different Lurasidone Formulations In Patients Schizophrenia | Phase 1 | 2008-07-01 |
| Completed | Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia Schizophrenia, Schizoaffective Disorder | Phase 3 | 2008-03-01 |
| Completed | Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Sub Generalized Anxiety Disorder | Phase 2 | 2008-01-01 |
| Completed | Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia Schizophrenia | Phase 3 | 2008-01-01 |
| Completed | A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects Asthma | Phase 2 | 2008-01-01 |
| Completed | A Safety, Efficacy and Tolerability Study of SEP-225289 Depressive Disorder, Major | Phase 2 | 2007-12-01 |
| Completed | Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD Chronic Obstructive Pulmonary Disease | Phase 4 | 2007-11-01 |
| Completed | Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia Schizophrenia | Phase 3 | 2007-10-01 |
| Completed | A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Pharmacokinetics | Phase 1 | 2007-08-01 |
| Completed | A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomni Major Depressive Disorder, Insomnia | Phase 3 | 2007-06-01 |
| Completed | SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS) Overactive Bladder Syndrome (OABS) | Phase 2 | 2006-12-01 |
| Completed | Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructiv Chronic Obstructive Pulmonary Disease, Bronchitis, Emphysema | Phase 4 | 2006-12-01 |
| Completed | A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia Insomnia | Phase 4 | 2006-10-01 |
| Completed | Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease Alzheimer's Disease | Phase 2 | 2006-02-01 |
| Completed | Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB Exercise-induced Bronchospasm | Phase 3 | 2005-12-01 |
| Completed | Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonar Chronic Obstructive Pulmonary Disease, Bronchitis, Emphysema | Phase 3 | 2005-10-01 |
| Completed | Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asth Asthma, Chronic Obstructive Pulmonary Disease, COPD | Phase 3 | 2005-09-01 |
| Completed | Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder Insomnia, Generalized Anxiety Disorder | Phase 4 | 2005-06-01 |
| Completed | Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Ch COPD | Phase 2 | 2005-04-01 |
| Completed | Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability Primary Insomnia | Phase 3 | 2005-04-01 |
| Completed | A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia Schizophrenia | Phase 2 | 2004-07-01 |
| Completed | A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia Schizophrenia | Phase 2 | 2004-05-01 |
| Completed | Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy V Insomnia | Phase 1 | 2004-03-01 |
| Completed | Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid A Insomnia, Arthritis, Rheumatoid | Phase 3 | 2004-02-01 |
| Completed | Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause Insomnia | Phase 3 | 2004-02-01 |
| Completed | A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder Insomnia, Depressive Disorder, Major | Phase 3 | 2004-01-01 |
| Completed | A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects W COPD | Phase 2 | 2003-10-01 |
| Completed | 6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia Primary Insomnia | Phase 3 | 2003-10-01 |
| Completed | Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS) Obstructive Sleep Apnea Syndrome | Phase 2 | 2003-08-01 |
| Completed | Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma Asthma | Phase 2 | 2003-06-01 |
| Completed | Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive P Asthma, COPD | Phase 4 | 2003-03-01 |
| Completed | Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma Asthma | Phase 2 | 2003-01-01 |
| Completed | Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With As Asthma | Phase 3 | 2003-01-01 |
| Completed | Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Race Asthma, Bronchoconstriction | Phase 2 | 2003-01-01 |
| Completed | Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma Asthma | Phase 3 | 2002-12-01 |
| Completed | Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma Asthma | Phase 3 | 2002-12-01 |
| Completed | Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Race Asthma, Bronchoconstriction | Phase 3 | 2002-10-01 |
| Completed | A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma Asthma | Phase 2 | 2002-10-01 |
| Completed | Safety and Tolerability Study of Drug to Treat Schizophrenia Schizophrenia | Phase 2 | 2002-09-01 |
| Completed | A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia Schizophrenia | Phase 2 | 2002-07-01 |
| Completed | To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD Chronic Obstructive Pulmonary Disease, Chronic Bronchitis, Emphysema | Phase 3 | 2002-06-01 |
| Completed | Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma Asthma | Phase 3 | 2002-05-01 |
| Completed | Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD Chronic Obstructive Pulmonary Disease, Chronic Bronchitis, Emphysema | Phase 3 | 2002-04-01 |
| Completed | Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2002-02-01 |
| Completed | A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary COPD | Phase 3 | 2002-02-01 |
| Completed | A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma Asthma | Phase 2 | 2001-10-01 |
| Completed | Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With Insomnia Primary Insomnia | Phase 3 | 2001-02-01 |
| Completed | Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD) Reactive Airways Disease (RAD) | Phase 3 | 2001-02-01 |
| Completed | Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma Asthma | Phase 3 | 2000-11-01 |